February 2014

Upping Their Game: CROs Must Develop A New Mindset to Partners with Sponsors

January 28, 2014

Contributed by: Mark Scullion, Senior VP, Strategic Resourcing, Inventiv Health Clinical As companies evaluate CRO partners, even for transactional work, they should be considering their potential fit for a more aligned relationship in the future. Forming an aligned partnership can lower costs, reduce oversight, and support the type of visionary goals that will deliver competitive […]

Creating Sustainable Growth, Profitability, and Innovation

January 28, 2014

Balkrishan Kalra, Senior Vice President & Global Business Leader, Life Sciences, Genpact Can your business process operations support disruptive new strategies, and nontraditional business models? Today, the life sciences industry faces unprecedented challenges, uncertainty and risk that are unlikely to abate anytime soon. Most players are exploring a variety of organizational strategies to adapt to […]

SHOWCASE FEATURE: Outsourcing: Adding Value to the Model

January 28, 2014

SHOWCASE FEATURE: Outsourcing: Outsourcing: Adding Value to the Model By Tarem Grom, Editor Outsourcing has become a standard worldwide business practice and management imperative and stakeholders are looking for more than cost- savings. A relatively small number of BPO clients — 20% of those participating in Accenture’s research study — have succeeded in extracting greater […]

C-Suite: Biotechnology

January 28, 2014

Biotechnology C-suite executives identify the biggest opportunities for innovation as well as the biggest barriers. Lloyd Everson, M.D CEO MolecularHealth Opportunities: The greatest opportunity for innovation within the biotechnology space lies in the rapidly increasing amount of data furthering the complexity of cell biology, and the ability to use it for clinical action. Big data […]

Singapore a Pharma Hub for Asia

January 28, 2014

Singapore a Pharma Hub for Asia By Kim Ribbink The pharma industry is increasingly drawn to Singapore, thanks to its commitment to research and innovation, good talent base, and trusted regulatory and IP environment. Singapore is fast becoming a leading regional and even global center for the life-sciences industry. According to Datamonitor, Singapore was the […]

Global Regulations Becoming More Uniform

January 28, 2014

Pharmaceutical companies must navigate a changing regulatory environment both here and abroad. As the digital age brings the clinical world closer together and research and development become more global, the industry needs to find a way to address regulatory requirements across myriad regions. The global regulatory environment is getting more rigorous, and regulators around the […]

Preparing for a Successful FDA Inspection

January 28, 2014

Pharmaceutical manufacturers need to be inspection ready, aligning their organization with the expectations of regulators. Preparing for successful inspections is not a one-time event. Being inspection ready means that pharmaceutical leaders are committed to managing compliance as part of their company culture. Industry experts say successfully managing compliance is something that is done every day […]

Rare Diseases: The Patient as Collaborator

January 28, 2014

In the rare disease market, working with patients and patient advocacy groups is critical for the success of new therapies. The voice of the patient is critical in healthcare. Nowhere is this more true than in the area of rare diseases. It’s critical to engage patients, industry experts say, to access the knowledge that patients […]

App Revolution: Avoiding the App Trap

January 28, 2014

App Revolution: Avoiding the App Trap The industry needs to create valuable apps that fill an unmet need and rise above the deluge of online services now available. Pocket.md, a directory of mobile medical applications, lists more than 1,500 mobile apps that have been produced by biotechnology, pharmaceutical, and medical device companies. Out of those […]

Specialty Drugs: An Evolving Commercial Model

January 28, 2014

A changing marketplace creates new challenges and new business models for specialty medications. At the same time the industry is increasing its focus on developing specialty drugs — a projected 40% growth by 2014 and 67% by 2015, according to Express Scripts — the reimbursement, marketing, and sales landscape of these products is also increasing […]

Last Word

January 28, 2014

Biopharmaceutical companies are becoming more fully ­engaged with patients as well as patient advocacy groups. Millennium’s head of patient advocacy, Tom Sellers, discusses the barriers and opportunities that early engagement entails. PV:What has precluded biopharmaceutical ­companies from early patient advocacy engagement? Sellers: I think in the past, the operating paradigm and the relationship between drug […]

Talent Pool

January 28, 2014

Pharma Pool Dr. Yong-Jun LIU Medimmune Names New Head of ­Research MedImmune, the global biologics research and development arm of AstraZeneca, has named Yong-Jun Liu, M.D., Ph.D., as the company’s new head of research. Most recently, Dr. Liu served as VP and chief scientific officer at the Baylor Research Institute and director of the Baylor […]

On the Calendar

January 28, 2014

The Calendar Industry Events and Conferences, including special discounts Coming Attractions IIR‚Äôs 23rd Annual Partnerships in Clinical Trials, March 30 – April 2, 2014, in Las Vegas, features more than 65 sessions and workshops covering a diverse range of perspectives appropriate for all levels within an organization, including voices from payers, patients, academia, and finance. […]

PharmaTrax

January 28, 2014

Pipelines are Shifting to Biotech Drugs Trending Now: Large molecules currently represent a dominant share of sales. The pharmaceutical industry, especially big pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs to include a rapidly increasing number of biotechnology products, according to a newly completed analysis from the Tufts […]

Tools of the Trade

January 28, 2014

GSW Launches Multi-Channel Detailing Platform Trending Now: eDetailing allows for increased flexibility and access to physicians in a changing salesforce landscape. GSW, an inVentiv Health company and healthcare communications agency, has released iQ.mercury 3, a significant advance in pharmaceutical detailing that is optimized both for Apple and Windows tablets. iQ.mercury 3 is a sales-effectiveness and […]

What’s New

January 28, 2014

CAHG and Diaceutics to Launch Bioceutics Trending Now: New agency is putting the “person” back into personalized healthcare. CAHG, a global professional healthcare communications company, and Diaceutics Ltd., specialists in personalized healthcare consulting, software, and services, have launched Bioceutics to develop communication strategies and educational and marketing campaigns specific to personalized healthcare. Bioceutics’ business model […]

Social Buzz

January 28, 2014

Trending Now: Only 50% of companies have developed meaningful social media programs, although the industry as a whole is beginning to move in the right direction. An IMS Health report, Engaging Patients through Social Media, takes a close look at the way pharmaceutical manufacturers are using social media, including Facebook, Twitter, YouTube, and Wikipedia to […]

Innovator’s Corner

January 28, 2014

The Fly Boy Dr. Ross Cagan’s approach to drug discovery aims to show how flies can be used to screen for new targets. The traditional process of finding a new drug starts by screening chemicals for their effect on a given target through cell-based screens. Modern drug discovery automates this, but it is still a […]

UpFront

January 28, 2014

INDUSTRY at Large AbbVie Provides Grant for Math Education AbbVie has provided a a $350,000 grant for math education to the North Chicago public schools. The grant will enable educators to strengthen and reinforce the math curriculum for students (K-8) in the district and assist in the implementation of an engaging, common core aligned curriculum […]

Letter to the Editor

January 27, 2014

Jonah Frohlich Managing Director Manatt Health Solutions The ACA is accelerating a ­reorganization of the healthcare delivery system from episodic, ­reactive, acute management of patients, to proactive, ­population-based delivery ­models. These changes, manifest as patient ­centered medical homes and accountable care organizations, ­require health plans and providers to aggressively manage high-risk ­patients, identify risk ­factors, […]

Letter from the Editor

January 27, 2014

The State of the Industry many companies are at a crossroads, according to Cegedim Relationship management. Cegedim Relationship Management recently engaged key decision makers from leading global life-sciences enterprises to address some critical questions: how has the recent transformational process shaped their perceptions and business operations? What targeted changes are manifesting themselves at current companies? […]

FEEDBACK